Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
6.11
+0.37 (6.45%)
At close: Feb 2, 2026, 4:00 PM EST
6.07
-0.04 (-0.65%)
After-hours: Feb 2, 2026, 7:24 PM EST
Cingulate Market Cap
Cingulate has a market cap or net worth of $43.89 million as of February 2, 2026. Its market cap has increased by 181.65% in one year.
Market Cap
43.89M
Enterprise Value
43.00M
1-Year Change
181.65%
Ranking
Category
Stock Price
$6.11
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $43.89M, a decrease of -31.72%. That is a compound annual growth rate of -8.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 41.24M | 40.61% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeonaBio | 44.25M |
| Anebulo Pharmaceuticals | 43.14M |
| INmune Bio | 42.27M |
| Galecto | 41.91M |
| Jasper Therapeutics | 41.42M |
| Lisata Therapeutics | 40.84M |
| Veru Inc. | 40.61M |
| Plus Therapeutics | 40.35M |